Short Acting Agents Vs Long Acting in Frequent Excerbator COPD Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
Chronic obstructive pulmonary disease is heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production, exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive ,airflow obstruction. There are network meta analysis to compare the efficacy and safety of short acting bronchodilators Vs long acting agents in treatment of COPD
Epistemonikos ID: 391f509f170b6a9984a9173c1596086193c63006
First added on: Feb 19, 2024